Ondine Biomedical Inc
F:VF5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Ondine Biomedical Inc
F:VF5
|
CA |
|
T
|
That Marketing Solution Inc
OTC:TSTS
|
US |
|
E
|
ENGlobal Corp
F:4EG
|
US |
|
B
|
BI Matrix Co Ltd
KOSDAQ:413640
|
KR |
|
Neurobo Pharmaceuticals Inc
NASDAQ:MTVA
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VF5's stock price target?
Not Available
VF5 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Ondine Biomedical Inc?
Projected CAGR
270%
Over the last 4 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 2 years is 270%.
What is the Gross Profit forecast for Ondine Biomedical Inc?
Projected CAGR
15%
Over the last 4 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 1 year is 15%.